Journey Medical Corp. (DERM)
7.77
-0.14
(-1.77%)
USD |
NASDAQ |
Aug 25, 11:22
Journey Medical Price to Book Value : 6.692 for Aug. 25, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 6.812 |
| August 21, 2026 | 6.674 |
| August 20, 2026 | 6.450 |
| August 19, 2026 | 5.865 |
| August 18, 2026 | 5.736 |
| August 17, 2026 | 5.564 |
| August 14, 2026 | 5.787 |
| August 13, 2026 | 5.727 |
| August 12, 2026 | 5.538 |
| August 11, 2026 | 5.443 |
| August 10, 2026 | 5.546 |
| August 07, 2026 | 5.538 |
| August 06, 2026 | 5.624 |
| August 05, 2026 | 5.512 |
| August 04, 2026 | 5.512 |
| August 03, 2026 | 5.572 |
| July 31, 2026 | 5.486 |
| July 30, 2026 | 5.555 |
| July 29, 2026 | 5.296 |
| July 28, 2026 | 5.434 |
| July 27, 2026 | 5.486 |
| July 24, 2026 | 5.331 |
| July 23, 2026 | 5.667 |
| July 22, 2026 | 6.132 |
| July 21, 2026 | 6.296 |
| Date | Value |
|---|---|
| July 20, 2026 | 6.106 |
| July 17, 2026 | 6.166 |
| July 16, 2026 | 6.123 |
| July 15, 2026 | 6.261 |
| July 14, 2026 | 6.132 |
| July 13, 2026 | 5.908 |
| July 10, 2026 | 5.951 |
| July 09, 2026 | 6.028 |
| July 08, 2026 | 5.753 |
| July 07, 2026 | 5.809 |
| July 06, 2026 | 6.218 |
| July 02, 2026 | 6.106 |
| July 01, 2026 | 6.063 |
| June 30, 2026 | 6.097 |
| June 29, 2026 | 6.020 |
| June 26, 2026 | 5.869 |
| June 25, 2026 | 5.514 |
| June 24, 2026 | 6.073 |
| June 23, 2026 | 5.94 |
| June 22, 2026 | 5.701 |
| June 18, 2026 | 5.514 |
| June 17, 2026 | 5.248 |
| June 16, 2026 | 5.417 |
| June 15, 2026 | 5.621 |
| June 12, 2026 | 5.621 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Nektar Therapeutics | 2.859 |
| ANI Pharmaceuticals, Inc. | 2.852 |
| Corcept Therapeutics, Inc. | 18.79 |
| Veru, Inc. | 1.652 |
| Johnson & Johnson | 7.755 |
Price to Book Value Related Metrics
| PS Ratio | 3.046 |
| Price | 7.77 |
| Earnings Yield | -2.98% |
| Market Cap | 214.90M |